MX2020004675A - Formulaciones de alcohol de seda. - Google Patents

Formulaciones de alcohol de seda.

Info

Publication number
MX2020004675A
MX2020004675A MX2020004675A MX2020004675A MX2020004675A MX 2020004675 A MX2020004675 A MX 2020004675A MX 2020004675 A MX2020004675 A MX 2020004675A MX 2020004675 A MX2020004675 A MX 2020004675A MX 2020004675 A MX2020004675 A MX 2020004675A
Authority
MX
Mexico
Prior art keywords
relates
present
aqueous formulation
alcohol formulations
alcohol
Prior art date
Application number
MX2020004675A
Other languages
English (en)
Spanish (es)
Inventor
Lin Römer
Jens Klein
Ralf Mehrwald
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of MX2020004675A publication Critical patent/MX2020004675A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
MX2020004675A 2017-11-10 2018-11-08 Formulaciones de alcohol de seda. MX2020004675A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17201049 2017-11-10
PCT/EP2018/080557 WO2019092073A1 (en) 2017-11-10 2018-11-08 Silk alcohol formulations

Publications (1)

Publication Number Publication Date
MX2020004675A true MX2020004675A (es) 2020-08-13

Family

ID=60301890

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020004675A MX2020004675A (es) 2017-11-10 2018-11-08 Formulaciones de alcohol de seda.

Country Status (8)

Country Link
US (1) US20200270316A1 (enExample)
EP (1) EP3706712A1 (enExample)
JP (2) JP7320846B2 (enExample)
KR (1) KR102686680B1 (enExample)
CN (2) CN118121684A (enExample)
MX (1) MX2020004675A (enExample)
SG (1) SG11202003987VA (enExample)
WO (1) WO2019092073A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7176736B2 (ja) 2016-02-11 2022-11-22 シービックス マテリアル サイエンシーズ リミテッド 合成のクモドラグラインシルクを含む複合材料
GB201915839D0 (en) 2019-10-31 2019-12-18 Givaudan Sa Hair care composition
WO2021214780A1 (en) 2020-04-23 2021-10-28 Seevix Material Sciences Ltd. Modified spider silk fiber and use thereof
US20250059704A1 (en) * 2021-12-07 2025-02-20 Amsilk Gmbh Use of a structural polypeptide for treating or finishing textiles
CN116425848B (zh) * 2023-04-11 2024-05-24 北京新诚中科技术有限公司 重组嵌合蛛丝蛋白、生物蛋白纤维及其制备方法和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1933021A (en) * 1930-08-07 1933-10-31 Maeder Preparation for use in curling hair
NL7713618A (nl) * 1976-12-11 1978-06-13 Bayer Ag Werkwijze voor de bereiding van een cosmetisch preparaat.
JPS5566929A (en) * 1978-11-13 1980-05-20 Kanebo Ltd Finely-powdered fibroin and its manufacture
JPH04300897A (ja) * 1991-03-28 1992-10-23 Kiyoichi Matsumoto 絹フィブロイン溶液
JP2997758B2 (ja) * 1996-01-23 2000-01-11 農林水産省蚕糸・昆虫農業技術研究所長 創傷被覆材
JP4074923B2 (ja) * 1997-12-25 2008-04-16 エンザミンインターナショナル株式会社 精製絹フィブロイン溶液及びその製造方法
FR2774588B1 (fr) * 1998-02-11 2000-05-05 Oreal Composition cosmetique ou dermatologique contenant au moins une proteine de soie d'arachnides naturelle, recombinante ou un analogue
JP2000319169A (ja) * 1999-05-13 2000-11-21 Ryoso:Kk 除菌剤とそれを用いた消毒方法
JP2002114616A (ja) * 2000-10-12 2002-04-16 Ryoso:Kk 除菌剤とそれを用いた消毒方法
JP4850709B2 (ja) * 2003-05-14 2012-01-11 ダニスコ・ユーエス・インコーポレーテッド 反復配列タンパク質ポリマーを使用する、活性剤の制御放出
AU2005263622B2 (en) * 2004-07-22 2012-04-26 Amsilk Gmbh Recombinant spider silk proteins
EP1919938B1 (en) * 2005-08-29 2012-06-06 AMSilk GmbH Modified spider silk proteins
KR20080056255A (ko) * 2005-10-05 2008-06-20 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 실크 단백질
CA2638870A1 (en) * 2006-01-20 2007-07-26 Basf Se Use of protein microbeads in cosmetics
US20110008437A1 (en) * 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
US20110052695A1 (en) * 2009-04-20 2011-03-03 Allergan, Inc. Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
WO2011120690A2 (en) 2010-03-31 2011-10-06 Amsilk Gmbh Separation of insoluble target proteins
CN102429835B (zh) * 2011-11-30 2013-05-01 广州好迪集团有限公司 发用角蛋白定型剂及发用定型品
RU2478706C1 (ru) * 2011-12-23 2013-04-10 Игорь Иванович Агапов Способ получения суспензий гидрогелевых микрочастиц с заданными размерами на основе рекомбинантного белка паутины и их применение
CN104822366B (zh) * 2012-07-13 2018-03-06 塔夫茨大学 在丝纤蛋白生物材料中香料和/或调味剂的包封
CN104884463B (zh) * 2012-12-27 2018-09-18 丝芭博株式会社 亲水性重组蛋白的提取方法
CN104327283B (zh) * 2014-10-16 2017-01-11 苏州经贸职业技术学院 一种复合丝素蛋白水凝胶及其制备方法、应用
BR112017023391B1 (pt) * 2015-04-29 2021-06-29 Silk Therapeutics, Inc. Composição e uso de uma composição
CN106310380B (zh) * 2016-08-19 2019-09-17 苏州大学 一种纳米纤维化丝素蛋白凝胶及其制备方法
JP7023950B2 (ja) * 2016-11-11 2022-02-22 アムシルク・ゲーエムベーハー センサとしての収縮性バイオポリマー繊維の使用

Also Published As

Publication number Publication date
SG11202003987VA (en) 2020-05-28
KR102686680B1 (ko) 2024-07-18
KR20200086328A (ko) 2020-07-16
CN118121684A (zh) 2024-06-04
JP2021502365A (ja) 2021-01-28
BR112020009041A2 (pt) 2020-11-03
JP7320846B2 (ja) 2023-08-04
JP2023153832A (ja) 2023-10-18
CN111491613A (zh) 2020-08-04
WO2019092073A1 (en) 2019-05-16
US20200270316A1 (en) 2020-08-27
EP3706712A1 (en) 2020-09-16

Similar Documents

Publication Publication Date Title
MX2020004675A (es) Formulaciones de alcohol de seda.
CL2017002727A1 (es) Composiciones de ácido obeticólico y métodos de uso
PE20180782A1 (es) Composiciones de insulina de accion rapida
MX386820B (es) Microcápsulas lipídicas que comprenden de preferencia un retinoide y composición que las contiene, su procedimiento de preparación y su uso en dermatología.
CR20160141A (es) Formulaciones de anticuerpos anti-pdl1
AR060130A1 (es) Formulacion de un anticuerpo monoclonal humano anti- igf-1r
CO2018001628A2 (es) Composiciones y formulaciones antimicrobianas
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
AR098168A1 (es) Formulación estable de insulina glulisina
AR109685A1 (es) Composiciones de nanopartículas y métodos para fabricarlas y usarlas
MX2015012833A (es) Composiciones antibioticas de ceftolozano.
MX391152B (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
CY1122310T1 (el) Εκχυλισμα γαρδενιας για τον χρωματισμο του δερματος
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CL2019002514A1 (es) Composiciones cosméticas para el cuidado de la piel.
CL2019002516A1 (es) Composiciones cosméticas para el cuidado de la piel.
BR112018012043A2 (pt) processo para a redução da transpiração
GEP20237486B (en) Formulations of copanlisib
MX388400B (es) Una composición de dos componentes, que comprende ácido acetilsalicílico.
BR112018008588A2 (pt) composição, e, processo para preparar uma composição.
BR112018071142A2 (pt) métodos de fabricação de formulações nutricionais
UY37444A (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y su uso
CO2019014831A2 (es) Nuevas formulaciones orales de belinostat
MX2018001188A (es) Formulacion de glucosinolatos y mirosinasa.
BR112018001793A2 (pt) preparação cosmética de redução do suor